Evidence suggests that tumor-derived pro-inflammatory cytokine IL-1β is essential for shaping tumor microenvironment in pancreatic cancer [25] by activating quiescent pancreatic stellate cells and driving them towards secretory phenotype to foster immunosuppressive milieu characterized by M2 macrophages and myeloid-derived suppressor cells. This evidence concerns the gene IL1B and familial pancreatic carcinoma.